IMPOYZ Drug Patent Profile
✉ Email this page to a colleague
When do Impoyz patents expire, and what generic alternatives are available?
Impoyz is a drug marketed by Primus Pharms and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-six patent family members in sixteen countries.
The generic ingredient in IMPOYZ is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Impoyz
A generic version of IMPOYZ was approved as clobetasol propionate by COSETTE on February 16th, 1994.
Summary for IMPOYZ
International Patents: | 26 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Patent Applications: | 4,524 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for IMPOYZ |
What excipients (inactive ingredients) are in IMPOYZ? | IMPOYZ excipients list |
DailyMed Link: | IMPOYZ at DailyMed |
Pharmacology for IMPOYZ
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for IMPOYZ
Paragraph IV (Patent) Challenges for IMPOYZ
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
IMPOYZ | Cream | clobetasol propionate | 0.025% | 209483 | 1 | 2019-12-06 |
US Patents and Regulatory Information for IMPOYZ
IMPOYZ is protected by thirteen US patents.
Patents protecting IMPOYZ
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF MODERATE PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Topical compositions comprising a corticosteroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF MODERATE PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: PLAQUE PSORIASIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IMPOYZ
See the table below for patents covering IMPOYZ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3267978 | COMPOSITIONS TOPIQUES COMPRENANT UN CORTICOSTÉROÏDE (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID) | ⤷ Try a Trial |
China | 107872972 | 包含皮质类固醇的外用组合物 (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID) | ⤷ Try a Trial |
Japan | 2013503203 | ⤷ Try a Trial | |
Spain | 2861374 | ⤷ Try a Trial | |
Eurasian Patent Organization | 037380 | КОМПОЗИЦИЯ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД (TOPICAL COMPOSITION COMPRISING A CORTICOSTEROID) | ⤷ Try a Trial |
Japan | 2021008505 | コルチコステロイドを含む局所用組成物 (TOPICAL COMPOSITIONS COMPRISING CORTICOSTEROID) | ⤷ Try a Trial |
Canada | 2979051 | COMPOSITIONS TOPIQUES COMPRENANT UN CORTICOSTEROIDE (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |